Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2006-7-3
pubmed:abstractText
Light-chain amyloidosis (AL) is characterized by immunoglobulin light-chain fragments aggregating into amyloid fibrils that deposit extracellularly in vital organs such as the kidney, the heart, and the liver, resulting in tissue degeneration and organ failure, leading to death. Cardiac involvement is found in 50% of AL patients and presents the most severe cases with a life expectancy of less than a year after diagnosis. In this study, we have characterized the variable domain of a cardiac AL patient light chain called AL-09. AL-09 folds as a beta-sheet and is capable of forming amyloid fibrils both in the presence of sodium sulfate and in self-seeded reactions under physiological conditions. Glycosaminoglycans such as dermatan sulfate and heparin promote amyloid formation of self-seeded AL-09 reactions, while the glycosaminoglycan chondroitin sulfate A stabilized oligomeric intermediates and did not elongate the preformed fibrils (nucleus) present in the reaction. Finally, the histological dye Congo red, known to bind to the cross beta-sheet structure of amyloid fibrils, inhibits AL-09 amyloid fibril formation in the presence of sodium sulfate and in self-seeded reactions. This paper provides insight into the impact of different reagents on light-chain stability, structure, amyloid fibril formation, and inhibition.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-10098877, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-10529258, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-10583407, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-10626146, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-1085290, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-10940217, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-10940230, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-11260801, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-11814343, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-12196128, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-12515719, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-12529361, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-12592027, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-12845610, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-14607088, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-14993413, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-15161647, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-15362105, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-15576561, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-15632012, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-15659393, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-15667222, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-15843464, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-16084781, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-2296158, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-2297939, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-2409350, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-3348956, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-3719098, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-4084449, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-6353059, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-6401828, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-7109539, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-7696573, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-7795526, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-7991613, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-8073293, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-8552301, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-8639594, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-9242912, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-9302305, http://linkedlifedata.com/resource/pubmed/commentcorrection/16751605-9341206
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0961-8368
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1710-22
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.
pubmed:affiliation
Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
pubmed:publicationType
Journal Article